Ascend Wellness Holdings (AAWH) Non-Current Assets (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Non-Current Assets came in at $683.1 million in Q1 2026, up 0.56% year-on-year from $679.4 million in Q1 2025, and down 2.27% quarter-over-quarter from $699.0 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Non-Current Assets (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Non-Current Assets history runs 7 years deep, the most recent figure standing at $683.1 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 0.56% year-over-year to $683.1 million in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 32.07% decrease from a year earlier, with the FY2025 full-year figure at $699.0 million, up 4.16% from the prior year.
  • Non-Current Assets retreated to $683.1 million in Q1 2026 per AAWH's latest filing, from $699.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $699.0 million in Q4 2025 and bottomed at -$208.8 million in Q3 2025.
  • The 5-year median for Non-Current Assets is $679.4 million (2025), against an average of $607.7 million.
  • Across the five-year window, Non-Current Assets jumped 189.73% in 2022 and plunged 130.6% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $673.4 million in 2022, then gained by 2.56% to $690.7 million in 2023, then slipped by 2.84% to $671.1 million in 2024, then increased by 4.16% to $699.0 million in 2025, then slipped by 2.27% to $683.1 million in 2026.
  • Per Business Quant, the three latest AAWH Non-Current Assets figures stand at $683.1 million (Q1 2026), $699.0 million (Q4 2025), and -$208.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn 683.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 683.13 Mn
Dec 31, 2025 698.98 Mn
Sep 30, 2025 -208.81 Mn
Jun 30, 2025 678.21 Mn
Mar 31, 2025 679.36 Mn
Dec 31, 2024 671.06 Mn
Sep 30, 2024 682.30 Mn
Jun 30, 2024 693.10 Mn
Mar 31, 2024 689.82 Mn
Dec 31, 2023 690.69 Mn
Sep 30, 2023 696.66 Mn
Jun 30, 2023 686.42 Mn
Mar 31, 2023 665.88 Mn
Dec 31, 2022 673.42 Mn
Sep 30, 2022 628.12 Mn
Jun 30, 2022 568.84 Mn
Mar 31, 2022 453.65 Mn
Dec 31, 2021 465.42 Mn
Sep 30, 2021 417.22 Mn
Jun 30, 2021 389.37 Mn